| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -1.33M | 100% | $9.19 | -$12.2M |
| Net | -2 | -1.33M | -100% | -$12.2M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | 10%+ Owner | $79.9M | Jan 1, 2022 | ||
| George Jay Goldsmith | 10%+ Owner | $62.2M | -$6.12M | -8.96% | May 20, 2024 |
| Ekaterina Malievskaia | 10%+ Owner | $62.2M | -$6.12M | -8.96% | May 20, 2024 |
| Kabir Nath | Chief Executive Officer, Director | $1.04M | Aug 1, 2024 | ||
| Teri Loxam | Chief Financial Officer | $655K | Mar 1, 2024 | ||
| Matthew Owens | General Counsel & CLO | $472K | Feb 1, 2024 | ||
| Michael Falvey | Chief Financial Officer | $188K | Feb 2, 2023 | ||
| Annalisa Jenkins | Director | $134K | Aug 1, 2024 | ||
| Mary-Rose Hughes | Interim CFO | $10.3K | Feb 1, 2024 | ||
| Thomas Lonngren | Director | May 9, 2024 | |||
| Robert McQuade | Director | May 9, 2024 | |||
| Daphne Karydas | Director | May 9, 2024 | |||
| Wayne Riley | Director | May 9, 2024 | |||
| Guy Goodwin | Chief Medical Officer | Feb 1, 2024 | |||
| Linda McGoldrick | Director | May 9, 2024 | |||
| David Norton | Director | May 9, 2024 | |||
| Gino Santini | Director | Sep 3, 2024 | |||
| Jason Camm | Director | Jan 1, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|